Skip to main content
SpringerLink
Log in

European researchers have found a genetic polymorphism in the tumour necrosis factor (TNF) receptor gene 1 in multiple sclerosis (MS) patients

  • Epidemiology population study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Gregory AP, Dendrou CA, Attfield KE, Haghikia A, Xifara DK, et al. TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis. Nature 488: 508-511, No. 7412, 08 Jul 2012. Available from: URL: http://dx.doi.org/10.1038/nature11307

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

European researchers have found a genetic polymorphism in the tumour necrosis factor (TNF) receptor gene 1 in multiple sclerosis (MS) patients. React. Wkly. 1417, 4 (2012). https://doi.org/10.2165/00128415-201214170-00012

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201214170-00012

Keywords

Search

Navigation